TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | NAN |
| S | %wins | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/20/21 16:08 | 10/19/21 | ETTX | Entasis Therapeutics Holdings Inc. | DE | Health | Drug | Pharmaceutical Preparations | Keiley Elizabeth M | MA | O | GC | S | -12 | 3.19 | 0 | -4 | -8 | 46 | D | ||||||||||||||
3/6/19 16:30 | 3/4/19 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | S | -70 | 17.00 | 0 | -4 | -13 | 27 | D | ||||||||||||||
6/16/17 16:32 | 6/15/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | S | -61 | 15.01 | 0 | -4 | -14 | 25 | D | ||||||||||||||
3/22/17 16:59 | 3/20/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | M.d | 9 | 0.8100 | 2 | 11 | 58 | 31 | D | 7 | 50 | 28 | 2 | 15 | 4 | 3 | 0 | 0 | 0 | 0 | |||
3/22/17 16:59 | 3/20/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Keiley Elizabeth M | X0 | O | SVP,GC | S.d | -48 | 16.05 | 2 | -3 | -9 | 31 | D | 7 | 50 | 28 | 2 | 15 | 4 | 3 | 0 | 0 | 0 | 0 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |